Frank van Schaijk

Statistics

Publications

Citations

H-Index

Active since

2004

Affiliations

Frank van Schaijk is an author at Boehringer Ingelheim (Germany) specializing in monoclonal antibodies, administration of monoclonal antibodies, and cancer immunotherapy.

Publications per year

2004–2004

Publications

Safety, Pharmacokinetics, Immunogenicity, and Biodistribution of <sup>186</sup> Re-Labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab( in Patients with Early-Stage Breast Cancer

Manuel J. Koppe, Frank van Schaijk, J. Roos et al. · Cancer Biotherapy and Radiopharmaceuticals · 2004 · 30 citations

Pharmacy, Oncology, Pharmacokinetics +17

1–1 of 1